Pharmaceutical industry

Bayer (2)
Dupont-merck (4)
Glaxosmithkline (1)
Pasteur-merieux (1)
Pharmaceutical industry (2)
Sanofi-aventis (1)

Synopsis: 5. medicine & health: Pharmaceutical industry:

said the company is basically taking the tracking system it uses for the pharmaceutical industry and adopting it to the food business.

Sleep Better Researchers at Merck have created a pill called suvorexant that essentially makes you a narcoleptic for a night.

pharmaceutical giant Sanofi, has manufactured 35 tons of artemisinin#roughly equivalent to 70 million courses of treatment.

says Johan Botterman, head of product research at Bayer Bioscience in Ghent, Belgium. The technique is established well for many crops,

) Bayer is interested in harnessing other enzymes called'meganucleases'to do the same type of targeted engineering,

While working at the Pasteur institute in Paris, he identified regulatory proteins that bind to DNA,

Every year the pharmaceutical industry spends more than $39 billion on R&d. According to the Food and Drug Administration liver toxicity is the most common reason for a drug to be pulled from clinical trials as well as from the marketplace after it's been approved.

and South africa thanks to a $400000 prize announced Nov 14 as part of the inaugural Healthcare Innovation Award program sponsored by pharmaceutical giant Glaxosmithkline and London-based nonprofit Save the Children.

However Merck Animal health manufacturer of Zilmax voluntarily suspended sales of the product last September when major U s. meat packer Tyson announced it would stop buying cattle fed Zilmax due to an animal welfare concern

While Merck recently announced that it is too early to determine when Zilmax will return to the market (Merck Animal health Shares Progress on Zilmax

and the Five-Step Plan for Responsible Beef) many feedlots might have switched to using a competing beta-agonist called Optaflexx or ractopamine.

< Back - Next >

Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011